HIV immune activity continued in the central nervous system of some adolescents being treated for HIV despite the virus being suppressed in their blood, according to trial data presented at the International AIDS Conference. The finding, from the Children with HIV Early Antiretroviral Therapy (CHER) trial, has implications for HIV cure research and any study that involves HIV treatment